We are focused on advancing the practice of less invasive stroke therapies through our Complete Stroke Care solutions. We are dedicated to providing innovative stroke products and services for ischemic and hemorrhagic stroke, and committed to providing clinical education and support to help physicians deliver better patient outcomes. More

Bold thinking. Bolder actions. We are Medtronic.

We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.

In everything we do, we are engineering the extraordinary.

MicroVention provides a complete approach to neuroendovascular technologies with 4 main product groups: Aneurysm Therapy Solutions, Ischemic Stroke & Carotid Artery Disease Solutions, Neurovascular Malformation Solutions, and Access Products.

Since 2005, phenox has been dedicated to developing innovative, breakthrough and clinically proven solutions for the treatment of neurovascular diseases like ischemic and hemorrhagic stroke.

Since 2014, Sim&Cure focus its activities to improve patient care by personalizing the therapeutic strategy by combining Digital Twin and AI technologies.
 

Balt has been collaborating with physicians for 45 years by providing them with differentiated and clinically relevant solution for the treatment of patients with neurovascular diseases.

Rapid Medical pioneers tools with Full adjustability and visibility provides real-time responsiveness, allowing physicians to tailor the procedure to each patient. TIGERTRIVER™ revascularization device, COMANECI™ temporary embolization-assist platform, DRIVEWIRE™ a guidewire with a steerable distal tip.

Asahi Intecc is a Japanese medical device company focused on delivering clinically unique devices such as guidewires, micro catheters and guiding catheters used in vascular procedures. Our neuro-vascular line-up includes CHIKAI guide wires (size between 008''- 018'') and FUBUKI guiding catheters.

Corindus is a global leader in robotic-assisted vascular interventions. The CorPath GRX System brings procedural precision, enhanced visualization, and an optimized work environment to interventions.

In the simplest sense, we’re a company that creates solutions. More specifically, we design novel access device technology for vascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That’s where we come in.

Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. During the Slice Next Frontiers, Philips will showcase the Neuro suite solution that supports high levels of procedural efficiency to help and redefine outcomes for your neuro patients.

CERENOVUS, part of Johnson & Johnson Medical Devices Companies, is a global leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke.

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

CereVasc, Inc., is a clinical-stage, venture-funded, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Its flagship product, the eShuntâ System, is intended to offer the first minimally invasive treatment for communicating hydrocephalus (CH) and an improvement to the current standard of care.

Cerus Endovascular

BCV's active guide wire: designed to facilitate the navigation through vascular tortuosities. Based on a smart handle and bvc's actuators technology to help the practitioners reaching the cerebral vessels.

https://www.basecampvascular.com/